DoD Amyotrophic Lateral Sclerosis Therapeutic Development Award
The Therapeutic Development Award supports the preclinical assessment of therapeutics for ALS. The proposed studies are expected to be empirical in nature and product-driven but may have a hypothesis-driven approach, provided the focus is on therapeutics. It is anticipated that the agents and/or data generated from these awards will lead to the advancement of new therapies for ALS.
General information about this opportunity
Last Known Status
Deleted 09/19/2014 (Archived.)
Program Number
W81XWH-14-ALSRP-TDA Federal Agency/Office
Agency: Department of DefenseOffice: U.S. Army Medical Research Acquisition Activity
Type(s) of Assistance Offered
Cooperative Agreement, Grant Number of Awards Available
2 What is the process for applying and being award this assistance?
Deadlines
08/20/2014 Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements. Who do I contact about this opportunity?
Headquarters Office
301-682-5507; help@eBRAP.org E-mail Address
help@eBRAP.org
Financial Information
Obligations
$4,800,000.00
